Regression of radiation-induced macular edema after systemic bevacizumab - PubMed (original) (raw)
Case Reports
doi: 10.3129/i07-140.
Affiliations
- PMID: 17823640
- DOI: 10.3129/i07-140
Case Reports
Regression of radiation-induced macular edema after systemic bevacizumab
Joel M Solano et al. Can J Ophthalmol. 2007 Oct.
Abstract
Case report: A 59-year-old patient with a coexisting primary choroidal melanoma and colorectal cancer was treated with external beam radiation (EBR) of his choroidal melanoma and systemic chemotherapy with leukovorin/5 fluorouracil (FU) for treatment of his metastatic colorectal cancer. Eight months following EBR, he showed evidence of radiation retinopathy with macular edema. Optical coherence tomography (OCT) showed macular edema and subretinal fluid. Subsequently, systemic bevacizumab (5 mg/kg) was added to his leukovorin/5FU chemotherapy. After the addition of bevacizumab, OCT showed complete resolution of the macular edema and subretinal fluid.
Comments: Bevacizumab may have a role in the treatment of radiation retinopathy, but further investigation is needed before any definitive conclusions can be made.
Similar articles
- Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO 3rd, Albert MA Jr, Persaud TO, Vail RS. Mason JO 3rd, et al. Retina. 2007 Sep;27(7):903-7. doi: 10.1097/IAE.0b013e31806e6042. Retina. 2007. PMID: 17891015 - Radiation maculopathy treated with intravitreal bevacizumab.
Sánchez-Vicente JL, Muñoz-Morales A, Galván-Carrasco MP, Castilla-Lázpita A, Vital-Berral C, Alfaro-Juárez A, Rueda-Rueda T. Sánchez-Vicente JL, et al. Arch Soc Esp Oftalmol. 2017 Jun;92(6):283-286. doi: 10.1016/j.oftal.2016.10.008. Epub 2016 Nov 25. Arch Soc Esp Oftalmol. 2017. PMID: 27894518 English, Spanish. - Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A, Muecke JS. Gupta A, et al. Retina. 2008 Jul-Aug;28(7):964-8. doi: 10.1097/IAE.0b013e3181706302. Retina. 2008. PMID: 18698298 - [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M, Steinbild S, Mross K. Medinger M, et al. Praxis (Bern 1994). 2004 Sep 29;93(40):1633-44. doi: 10.1024/0369-8394.93.40.1633. Praxis (Bern 1994). 2004. PMID: 15495753 Review. German. - Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
Augustine H, Munro M, Adatia F, Webster M, Fielden M. Augustine H, et al. Can J Ophthalmol. 2014 Oct;49(5):458-63. doi: 10.1016/j.jcjo.2014.06.008. Can J Ophthalmol. 2014. PMID: 25284103 Review.
Cited by
- Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy.
Brito IA, Zacharias LC, Pimentel SL. Brito IA, et al. Case Rep Ophthalmol Med. 2015;2015:516921. doi: 10.1155/2015/516921. Epub 2015 Oct 8. Case Rep Ophthalmol Med. 2015. PMID: 26635985 Free PMC article. - Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.
Jain RK. Jain RK. Cancer Cell. 2014 Nov 10;26(5):605-22. doi: 10.1016/j.ccell.2014.10.006. Epub 2014 Nov 10. Cancer Cell. 2014. PMID: 25517747 Free PMC article. Review. - Bevacizumab and intraocular tumors: an intriguing paradox.
el Filali M, Ly LV, Luyten GP, Versluis M, Grossniklaus HE, van der Velden PA, Jager MJ. el Filali M, et al. Mol Vis. 2012;18:2454-67. Epub 2012 Oct 5. Mol Vis. 2012. PMID: 23077404 Free PMC article. - Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.
Jain RK. Jain RK. J Clin Oncol. 2013 Jun 10;31(17):2205-18. doi: 10.1200/JCO.2012.46.3653. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669226 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical